天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
Chinese English Japanese Germany Korea
010-86108875
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Mirabegron
223673-61-8

Mirabegron synthesis

2synthesis methods
Mirabegron (formerly YM-178, trade name Myrbetriq) is a drug for the treatment of overactive bladder. It was developed by Astellas Pharma and was approved in the United States in July 2012. Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity.
Synthetic Routes
  • ROUTE 1
  • 202112074813927619.jpg

    Vedantham, Ravindra; Kandagatla, Bhaskar; Vyala, Sunitha; Raju, V. V. N. K. V. Prasada; Cherukupalli, Praveen; Iqbal, Javed; Dahanukar, Vilas H.; Kagga, Mukkanti; Bandichhor, Rakeshwar; Oruganti, Srinivas. Practical synthesis of Mirabegron. Journal of Chemical and Pharmaceutical Research. Volume 7. Issue 4. Pages 1473-1478. Journal; Online Computer File. (2015).

  • ROUTE 2
  • 202112076817393891.jpg

    Xu, Guiqing; Mao, Shen; Mao, Longfei; Jiang, Yuqin; Zhou, Yong; Shen, Jiaxuan; Dong, Wenpei. Study on a New Method for Synthesis of Mirabegron. Journal of Heterocyclic Chemistry. Volume 54. Issue 5. Pages 2703-2707. Journal; Online Computer File. (2017).

  • ROUTE 3
  • 202112071868643826.jpg

    De Angelis, Sonia; Carlucci, Claudia; de Candia, Modesto; Rebuzzini, Gabriele; Celestini, Paolo; Riscazzi, Massimiliano; Luisi, Renzo; Degennaro, Leonardo. Targeting a Mirabegron precursor by BH3-?mediated continuous flow reduction process. Catalysis Today. Volume 308. Pages 81-85. Journal; Online Computer File. (2018).

  • ROUTE 4
  • 202112077935106489.jpg

    Zhang, Lei; Tan, Zhimin; Jiao, Huirong; Qiu, Pengcheng; Zhang, Fuli. Synthesis of related substance of mirabegron. Zhongguo Yiyao Gongye Zazhi. Volume 45. Issue 1. Pages 9-12. Journal. (2014).

  • ROUTE 5
  • 202112073602980458.jpg

    : Jung, In Hwa; Lee, In Gyu; Mo, Gil Ung; Han, Hae Su; Han, Ga Ram; Shin, Jae Won; Kim, Hyeon Jeong; Kim, A. Reum; Jung, Gi Won; Ahn, Ji Hun. Preparation of salts of amide derivatives. Assignee?Sungwun Pharmacopia Co., Ltd., S. Korea. KR?2018138058. (2018).

  • ROUTE 6
  • 202112074958650571.jpg

    Shankar, Rama; Chavhan, Bhausaheb; Tummalapalli, Umasankara Sastry; Talatala, Appi Reddy; Pareddi, Gandhi. An improved process for the preparation of Mirabegron. Assignee?Mylan Laboratories Ltd., India. IN?2013CH02517. (2016).

  • ROUTE 7
  • 202112071665339634.jpg

    Pradhan, Nitin Sharadchandra; Patil, Nilesh Sudhir; Walavalkar, Rajesh Ramchandra; Kulkarni, Nilesh Subhash; Rawool, Santosh Namdev; Awate, Purushottam Ekanath. A process for the preparation of mirabegron and its intermediates. Assignee?Wanbury Ltd., India. IN?2014MU02534. (2016).

  • ROUTE 8
  • 202112077128527587.jpg

    Li, Wei; Mao, Shen; Mao, Longfei; Jiang, Yuqin; Zhang, Yingui; Yuan, Lishuang; Xu, Guiqing; Dong, Wenpei; Jiang, Tao. Process for the preparation of mirabegron. Assignee?Henan Normal University, Peop. Rep. China. CN?105111165. (2015).

  • ROUTE 9
  • 202112074758357164.jpg

    Hu, Fan; Wang, Shenyong; Jia, Xinzan; Wang, Xiaojun; Hu, Junkai. Process for synthesis of Mirabegron. Assignee?Suzhou Uugene Biopharma Co., Ltd., Peop. Rep. China. CN?103193730. (2013).

202112074813927619.jpg

Vedantham, Ravindra; Kandagatla, Bhaskar; Vyala, Sunitha; Raju, V. V. N. K. V. Prasada; Cherukupalli, Praveen; Iqbal, Javed; Dahanukar, Vilas H.; Kagga, Mukkanti; Bandichhor, Rakeshwar; Oruganti, Srinivas. Practical synthesis of Mirabegron. Journal of Chemical and Pharmaceutical Research. Volume 7. Issue 4. Pages 1473-1478. Journal; Online Computer File. (2015).

29676-71-9 Synthesis
2-Aminothiazole-4-acetic acid

29676-71-9
454 suppliers
$13.00/5g

521284-22-0 Synthesis
(alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride

521284-22-0
195 suppliers
$10.00/250mg

-

Yield:223673-61-8 84.5%

Reaction Conditions:

with hydrogenchloride;1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride in water at 28; for 3 h;Concentration;

Steps:

1d Example idStep d: Preparation of a-form of crystalline (R)-2-(2-aminothiazol-4-yl)-4 ‘-12- F(2-hydroxy- 2-phenylethylaminol -ethyll -acetanilide (Mirabepron)
To a mixed solution of (100 g) (R)-2-[[2-(4-aminophenyl)ethyl]-amino]-l-phenylethanolmonohydrochioride (prepared according to example Ic), 2-aminothiazole-4-yl-acetic acid (55.10 g), concentrated hydrochloric acid (35.61 g) and water (1500 mL); 1-(3-dimethylaminopropyl)-3- ethylcarbodiimide monohydrchloride (EDC.HCI) (72.01 g) was added at 28°C (±2) and the mixture was stirred for 1 hr. l-(3-dimethylaminopropyl)-3-ethylcarbodiimide monohydrochioride (EDC.HCI) (7.2 g) was added into the mixture at 28°C (±2) and the mixture was stirred for 2 hrs. The reaction mass was washed with mixture of ethyl acetate (400 mL) and n-butanol (100 mL). To the reaction mixture, n-butariol (1000 mL) was added followed by addition of aqueous solution of ammonia (20%, 80 mL). The organic layer was separated and successively washed with aqueous ammonia (5%, 1000 mE) and then followed by water. The organic layer was partially concentrated under vacuo and the temperature was raised to 68°C (±2). To this solution, toluene (1400 mE) was added and gradually cooled to room temperature. The solid obtained was filtered, washed with toluene and dried under vacuo at 48°C (±2) to obtain crystals of CL form of Mirabegron having PXRD pattern shown in Fig. 1 and Infrared spectrum (IR) show in Fig 2.Yield: 114.1 g (84.5%); Purity by HPLC: 99.80%.

References:

MEGAFINE PHARMA (P) LTD.;MATHAD, Vijayavitthal Thippannachar;DESHMUKH, Dattatray Gulabrao;VARPE, Sagar Popat;NAVALE, Pravin Mahadu WO2015/44965, 2015, A1 Location in patent:Page/Page column 34; 36

FullText

Mirabegron Related Search: